Galera to present at three upcoming investor conferences in september

Malvern, pa., sept. 07, 2021 (globe newswire) -- galera therapeutics, inc. (nasdaq: grtx), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that mel sorensen, m.d., president and chief executive officer, will present at three upcoming virtual investor conferences in september.
GRTX Ratings Summary
GRTX Quant Ranking